Mr. Speaker, I can reassure the public that the Public Health Agency remains in contact with partners to better understand these recent cases.
Specifically in relation to EV-D68, we are monitoring these cases closely. The member and the public should know that the agency is in close contact with provinces and territories and with U.S. public health officials, and we stand ready to support the provinces and territories with any lab support or guidance that they may need.